CAR-T: A DEMI-DECADE IN THE REAL WORLD

This panel will reflect on the remarkable journey of CAR-T therapies over the past five years, exploring their impact on patients in real-world scenarios. Our expert panelists will highlight clinical data and share positive outcomes observed with commercial CAR-T products. Discover the tangible benefits these therapies have brought to the broader patient community thus far and gain valuable insights into what the future holds for CAR-T advancements.
Moderator:
Delara Motlagh, Ph.D., Head of Global Cell Therapy, Catalent
Speakers:
Robert Ang, M.D., President and CEO, Vor Bio
Christian Chabannon, M.D., Ph.D., Head and QP, Centre de Thérapie Cellulaire, Institut Paoli-Calmettes, Comprehensive Cancer
Emil Cochino, M.D., Scientific Senior Specialist (Risk Management), Advanced Therapies and Haematological Diseases, EMA
Lucy Ellerker-Jones, Founder, Opie Jones Foundation